Dangerous Drug Interactions: A Quick Quiz

Prostate Cancer Treatment: Navigating Drug Interactions Bucharest – May 9, 2024 – Prostate cancer treatment involves careful management of drug interactions, as certain medications can pose risks when combined. This article explores the challenges of navigating these interactions,specifically concerning relugolix,a gonadotropin-releasing hormone antagonist. When is it a concern? Healthcare providers and patients must be aware … Read more

Can Adding Radium-223 to RT Boost Prostate Cancer Outcomes?

TOPLINE: Adding radium-223 dichloride (Ra223) to metastasis-directed stereotactic ablative radiotherapy (SABR) did not improve progression-free survival compared with SABR alone in men with bone-only oligometastatic castration-sensitive prostate cancer, according to a phase 2 trial. However, the authors identified two potential prognostic biomarkers — high-risk DNA mutations and T-cell receptor repertoire diversity — to predict progression-free … Read more

‘I Forgot I Was 7000 Miles Away’ During Surgical First

On a cold Wednesday morning in January, Ruben Olivares, MD, sat down at a computer workstation in Cleveland to perform surgery on a man with prostate cancer. Olivares, a urologist at Cleveland Clinic, Cleveland, directed a robot to send high-intensity, focused ultrasound waves to the tumor. But this time, the patient was not in a … Read more

Improved Treatment for Low-Grade PC Lesions

Archyde Expert Groups Advocate for Refined Approach to Diagnosing Indolent prostate Cancer May 8, 2025 Two leading international pathology societies are urging a shift in how indolent prostate cancers are detected and diagnosed, aiming to reduce overtreatment and improve patient outcomes. Teh Genitourinary Pathology Society (GUPS) and the International Society of Urological Pathology (ISUP) recently … Read more

Radiotherapy for Prostate Cancer: What Approach Works Best?

TOPLINE: Moderately hypofractionated radiotherapy, both isodose and dose-escalated, led to progression-free survival outcomes similar to that achieved with conventionally fractionated radiotherapy in patients with prostate cancer, but the dose-escalated regimen came with an increased risk for toxicities compared with the conventional approach, according to findings from a recent meta-analysis. METHODOLOGY: Moderately hypofractionated radiotherapy is now … Read more

Prostate Cancer Patient Develops Rare Penile Metastases

Key Takeaways For men with genitourinary malignancies, such as prostate cancer, examining the external genital area is essential. While this may seem routine, it remains a crucial recommendation, as illustrated by the case of a patient reported by Portuguese physicians led by José Laert from the Department of Radiology, Hospital CUF Tejo, Lisbon, Portugal. The … Read more

Acute EOL Care Increased in Patients With Advanced Cancer

TOPLINE: Among Medicare beneficiaries with advanced cancer, 45% had more than one acute care visit, in-hospital mortality, late receipt of systemic therapy, or hospice entry in the last 30 days of life. METHODOLOGY: Historical evidence has shown that patients with advanced cancer often receive potentially aggressive care at the end of life, including late initiation … Read more

Optimizing Senior Healthcare: Minimizing Unnecessary Tests with Ongoing Efforts

Minimizing Needless Medical Procedures in Elderly Patients Table of Contents Minimizing Needless Medical Procedures in Elderly Patients Minimizing Unnecessary Procedures Challenges in Reducing Screenings Prostate Screening: A Persistent Challenge Diabetes Treatment: Balancing Benefits and Risks Urine Screening: A Positive Outcome Enhancing Clinical Efficiency with Pop-Ups Challenges in Reducing Unnecessary Medical Screenings Prostate Cancer Screening: An … Read more

Cutting Needless Tests for Seniors Requires Ongoing Effort

Reducing unnecessary and potentially harmful tests and treatment of geriatric patients may require ongoing interventions, according to new research published in Annals of Internal Medicine. At the end of a year-long follow-up to an 18-month randomized controlled trial, reductions in overuse rebounded in two out of three areas. The first: Prostate-specific antigen (PSA) testing of … Read more

‘Man Van’ Diagnoses Nonmetastatic Prostate Cancers

Among more than 3000 men from low-income communities who were screened for various health issues at mobile clinics, one had stage IV and none had metastatic prostate cancer. These were among the findings of a study presented by lead author Masood Moghul, MBBS, at the 2025 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium … Read more